These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1990605)
1. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo. Yuh DD; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605 [No Abstract] [Full Text] [Related]
2. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228 [No Abstract] [Full Text] [Related]
3. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Yuh DD; Morris RE Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226 [TBL] [Abstract][Full Text] [Related]
4. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. Morris RE; Wu J; Shorthouse R Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111 [No Abstract] [Full Text] [Related]
5. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698 [No Abstract] [Full Text] [Related]
6. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro. Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631 [No Abstract] [Full Text] [Related]
8. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation. Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115 [No Abstract] [Full Text] [Related]
9. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates. Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423 [No Abstract] [Full Text] [Related]
10. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428 [No Abstract] [Full Text] [Related]
12. Effect of a new immunosuppressant, 15-deoxyspergualin, on heterotopic rat heart transplantation, in comparison with cyclosporine. Suzuki S; Kanashiro M; Amemiya H Transplantation; 1987 Oct; 44(4):483-7. PubMed ID: 3313835 [TBL] [Abstract][Full Text] [Related]
13. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493 [No Abstract] [Full Text] [Related]
14. Efficacy of didemnin B in suppressing allograft rejection in mice and rats. Yuh DD; Zurcher RP; Carmichael PG; Morris RE Transplant Proc; 1989 Feb; 21(1 Pt 1):1141-3. PubMed ID: 2650081 [No Abstract] [Full Text] [Related]
15. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model. Gannedahl G; Wanders A; Carlsson M; Tufveson G Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473 [No Abstract] [Full Text] [Related]
16. Effects of cyclosporine and 15-deoxyspergualin on coronary arteriosclerosis after heart transplantation in the rat. Nagamine S; Ohmi M; Tabayashi K; Iguchi A; Mohri H J Heart Lung Transplant; 1994; 13(5):895-8. PubMed ID: 7803433 [TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin. Iga C; Okajima K; Takeda Y; Tezuka K Transplant Proc; 1990 Aug; 22(4):1658. PubMed ID: 1697118 [No Abstract] [Full Text] [Related]
18. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts. Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689 [No Abstract] [Full Text] [Related]
19. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation. Ueda H; Itoh S; Kusaka M; Isurugi K Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046 [No Abstract] [Full Text] [Related]
20. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]